Emily Orr attended the National Institute of Drug Abuse (NIDA) Genetics and Epigenetics Cross-Cutting Research Team Meeting at NIH headquarters in Bethesda MD, May 2024. She presented her poster, “Applying high Throughput deep mutational scanning to study transcription factors implicated in the biology of substance use disorders”.
The meeting featured over 200 researchers covering GWAS, longitudinal genetic risk assessment studies, the utility All of Us research data and future directions, amongst several functional assessments.